Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients
Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients
Enrolling by invitation · NCT05947825 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients | PDAC - Pancreatic Ductal Adenocarcinoma | Enrolling by invitation | Phase 2 | 2026-07-13 | NCT05947825 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | 287 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tianjin Medical University Cancer Institute & Hospital | Tianjing | China | 1 |